New p53 knockout rat model introduced to improve timelines for carcinogenicity screening
April 20th, 2010

- Image via Wikipedia
Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world’s first p53 ‘knockout’ rat model, an important development that is expected to, due to the rat’s closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=c0582340-9abd-4f98-bb41-68678718e26f)







